
CDMO News
CiVentiChem Expands Manufacturing Capacity by 300% with New Facility
CiVentiChem, a Contract Development and Manufacturing Organization (CDMO), has completed a new facility that significantly increases its manufacturing capacity by 300%. This expansion is aimed at producing Regulatory Starting Materials (RSMs) and intermediates, supporting both small molecule clinical and commercial